Dr Paul Witting is an Associate Professor in the Discipline of Pathology at The University of Sydney and a career biomedical researcher. He has held ARC (2003-2007) and National Heart Foundation Fellowships (1999-2001) that financed post-doctoral terms at the ANZAC Research Institute and University of British Columbia (Canada), respectively. He has a proven track record in the field of bio-medical chemistry publishing 87 peer-reviewed papers (mean impact factor (IF) ~4.8 with >90% appearing in international journals); 4-book chapters; 9-invited review articles and one International Patent. [More...]

Dr Paul Witting is an Associate Professor in the Discipline of Pathology at The University of Sydney and a career biomedical researcher. He has held ARC (2003-2007) and National Heart Foundation Fellowships (1999-2001) that financed post-doctoral terms at the ANZAC Research Institute and University of British Columbia (Canada), respectively. He has a proven track record in the field of bio-medical chemistry publishing 87 peer-reviewed papers (mean impact factor (IF) ~4.8 with >90% appearing in international journals); 4-book chapters; 9-invited review articles and one International Patent.

Publications by Witting and his co-workers have been acknowledged with 2144 citations (mean citation/publication ~23 yielding an H-index ~31). He has been awarded ~A$5.9 Million in competitive funding from agencies including the ARC, NHF, Wellcome Trust, NHMRC Equipment Grants, The Ramaciotti, Bushell and CASS Foundations, Eli Lilly Diabetes Foundation, Diabetes Australia Research Trust and the University of Sydney Strategic Development Grants Scheme.

In July of 2008 Witting moved from the ANZAC Research Institute to take up a full time Senior Lectureship and establish the Redox Biology Group in the Discipline of Pathology, The new facility combined with significant funding from the ARC over the next 2-3 years provides an excellent environment for young researchers to be trained in biomedical techniques and explore the relationships between oxidative stress and disease. [Hide detail]